IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — CING

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022
Cash & Equivalents28.4025.896.128.909.5210.040.381.111.990.351.749.808.2012.61
Short-term Investments--------------------------0.00
Accounts Receivable----------0.001.62--------------
Total Current Assets30.2127.917.4310.2210.5011.342.522.732.902.043.7511.8310.1014.57
Property, Plant & Equipment1.631.671.691.801.942.072.372.462.532.692.842.852.953.05
Total Non-current Assets*2.862.953.093.251.962.242.612.772.973.193.413.543.703.86
Total Assets33.0730.8610.5213.4712.4713.585.135.495.875.237.1615.3813.8018.43
Accounts Payable1.992.670.870.870.860.911.330.741.671.610.600.390.280.56
Total Current Liabilities8.6310.965.886.735.621.542.042.255.7310.996.666.410.921.63
Total Non-current Liabilities*0.971.041.161.220.920.000.000.030.230.330.420.600.700.78
Total Liabilities9.6012.007.057.966.541.542.042.285.9711.337.087.011.622.41
Retained Earnings(147.56)(141.69)(126.10)(117.08)(112.29)(102.36)(99.13)(95.92)(86.01)(80.03)(73.41)(64.80)(60.78)(56.74)
Total Stockholder Equity23.4718.863.475.515.9312.043.083.22(0.10)(6.10)0.088.3712.1816.02

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Research & Development1.492.182.002.852.702.224.331.431.881.814.983.924.462.131.932.122.182.761.26
Selling, General & Admin3.935.743.583.151.951.481.881.851.331.141.811.831.911.722.541.851.872.251.38
Operating Income(5.41)(7.92)(5.59)(6.00)(4.65)(3.71)(6.21)(3.28)(3.21)(2.95)(6.80)(5.75)(6.36)(3.85)(4.48)(3.97)(4.05)(5.01)(2.65)
Interest Expense------------------0.030.110.240.250.19--0.10------
Pretax Income(5.87)(9.31)(6.52)(7.34)(4.79)(3.80)(6.13)(3.23)(3.21)(2.97)(6.93)(5.98)(6.62)(4.00)(4.61)(4.03)(4.04)(5.00)(2.65)
Net Income(5.87)(9.31)(6.52)(7.34)(4.79)(3.80)(6.13)(3.23)(3.21)(2.97)(6.93)(5.98)(6.62)(4.00)(4.61)(4.03)(4.04)(5.00)(2.65)
Basic EPS(0.45)(0.95)(0.96)(1.35)(1.09)(1.04)(0.14)(1.83)--(0.60)(24.78)(0.30)(0.57)(0.35)(0.40)(0.36)(0.36)(0.44)--
Diluted EPS(0.45)(0.95)(0.96)(1.35)(1.09)(1.04)(2.30)(1.83)(5.47)(0.60)(24.84)(0.30)(0.57)------------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(5.90)(6.91)(3.60)(4.24)(4.80)(4.61)(4.08)(3.88)(1.74)(8.75)(2.56)(4.29)(4.60)(3.58)(4.21)(3.40)(4.41)(3.86)
Capital Expenditures0.070.060.160.000.01--0.20(0.14)0.070.080.190.000.000.040.140.000.000.01
Free Cash Flow*(5.97)(6.97)(3.75)(4.24)(4.80)--(4.28)(3.74)(1.81)(8.83)(2.75)(4.29)(4.60)(3.61)(4.35)(3.40)(4.41)(3.87)
Investing Cash Flow(0.07)(0.06)(0.16)0.00(0.01)--(0.20)0.14(0.07)(0.08)(0.19)0.00-0.00(0.04)(0.14)0.00-0.00(0.01)
Financing Cash Flow8.4821.918.591.464.181.926.4513.401.089.890.825.933.21-0.00(0.09)5.00-0.00-0.00

* Derived from reported values